Key statistics
As of last trade, Antengene Corp Ltd (722:FRA) traded at 0.358, 353.16% above the 52 week low of 0.079 set on Feb 10, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 0.358 |
|---|---|
| High | 0.358 |
| Low | 0.358 |
| Bid | 0.354 |
| Offer | 0.402 |
| Previous close | 0.346 |
| Average volume | 18.44 |
|---|---|
| Shares outstanding | 679.24m |
| Free float | 411.46m |
| P/E (TTM) | -- |
| Market cap | 2.31bn HKD |
| EPS (TTM) | -0.4142 HKD |
Data delayed at least 15 minutes, as of Feb 10 2026 07:06 GMT.
More ▼
Press releases
- Antengene Presents at JPM: Strong Clinical Data Update and Strategic Focus on Next-Generation ADCs and TCEs
- Antengene Expands XPOVIO® Indications in Malaysia with Approval in Diffuse Large B-cell Lymphoma
- Antengene Announces IND Approval in China for Phase Ib/II Study of ATG-022 (CLDN18.2 ADC) in Combination with KEYTRUDA® (Pembrolizumab) ± Chemotherapy
- Antengene Hosts 2025 R&D Day Showcasing Encouraging Clinical Data and Solid Progress with Investigational Programs
